Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Annals of Surgical Oncology
|
June 11, 2021
Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma
Eddie Zhang, Lora Wang, Talha Shaikh, et al.
Cancer
|
December 8, 2024
Efficacy of a couple-based intervention addressing sexual concerns for breast cancer survivors: Results of a randomized controlled trial
Jennifer Barsky Reese, Stephen J Lepore, Kristen A Sorice, et al.
Oncotarget
|
August 13, 2015
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
Tim N Beck, John Kaczmar, Elizabeth Handorf, et al.
JAMA Network Open
|
August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer Treatment
Zachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
European Journal of Haematology
|
March 20, 2023
Venous thromboembolism in metastatic pancreatic cancer
Lauren Laderman, Krishnalatha Sreekrishnanilayam, Ramesh K Pandey, et al.
European Urology Focus
|
February 19, 2022
The Delayed Nephrogram: Point-of-care Quantitative Measurement, Validation as an Indicator of Obstruction, and Novel Use as a Predictor of Renal Functional Impairment
Marshall C Strother, Eric Y Cho, Matt Loecher, et al.
Breast Cancer Research and Treatment
|
October 22, 2018
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
Anna M Mazor, Alina M Mateo, Lyudmila Demora, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 2, 2024
Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers
Marci Macaraeg, Elizabeth Baker, Elizabeth Handorf, et al.
The Oncologist
|
June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Julia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
Nature Communications
|
August 21, 2019
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Ilya G Serebriiskii, Caitlin Connelly, Garrett Frampton, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Annals of Surgical Oncology
|
June 11, 2021
Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma
Eddie Zhang, Lora Wang, Talha Shaikh, et al.
Cancer
|
December 8, 2024
Efficacy of a couple-based intervention addressing sexual concerns for breast cancer survivors: Results of a randomized controlled trial
Jennifer Barsky Reese, Stephen J Lepore, Kristen A Sorice, et al.
Oncotarget
|
August 13, 2015
Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
Tim N Beck, John Kaczmar, Elizabeth Handorf, et al.
JAMA Network Open
|
August 14, 2023
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer Treatment
Zachary A K Frosch, Jill Hasler, Elizabeth Handorf, et al.
European Journal of Haematology
|
March 20, 2023
Venous thromboembolism in metastatic pancreatic cancer
Lauren Laderman, Krishnalatha Sreekrishnanilayam, Ramesh K Pandey, et al.
European Urology Focus
|
February 19, 2022
The Delayed Nephrogram: Point-of-care Quantitative Measurement, Validation as an Indicator of Obstruction, and Novel Use as a Predictor of Renal Functional Impairment
Marshall C Strother, Eric Y Cho, Matt Loecher, et al.
Breast Cancer Research and Treatment
|
October 22, 2018
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
Anna M Mazor, Alina M Mateo, Lyudmila Demora, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 2, 2024
Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers
Marci Macaraeg, Elizabeth Baker, Elizabeth Handorf, et al.
The Oncologist
|
June 28, 2017
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors
Julia Judd, Matthew Zibelman, Elizabeth Handorf, et al.
Nature Communications
|
August 21, 2019
Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Ilya G Serebriiskii, Caitlin Connelly, Garrett Frampton, et al.
Page
of 12